Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNK333 in Female Patients With IBS-D
NCT00394173Phase 2Completed
- Sponsor
- Novartis
- Start
- Sep 2006
- Primary completion
- Oct 2007
- Countries
- 2
01
Overview
A Phase 2 trial of DNK333 in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Novartis. Started Sep 2006; status: completed.
02
Drugs
DNK333
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00394173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00394173.